These include aberrant gonadotropin secretion patterns with a shift of balance toward elevated luteinizing hormone (LH) levels and insulin resistance leading to compensatory hyperinsulinemia, both of which directly and indirectly lead to clinical or subclinical hyperandrogenemia. Here, PLOD1 is linked to polycystic ovary syndrome.